Dynamic Technology Lab Private LTD Bluebird Bio, Inc. Transaction History

Dynamic Technology Lab Private LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.32 - $4.83 $35,323 - $129,250	26,760 New	26,760 $37,000
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $96,684 - $174,309	34,654 New	34,654 $114,000
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $12,030 - $21,401	-4,092 Reduced 12.72%	28,075 $116,000
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $130,919 - $340,970	32,167 New	32,167 $156,000
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $242,222 - $452,550	-21,550 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$18.04 - $22.09 $388,762 - $476,039	21,550 New	21,550 $689,000
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $181,274 - $239,679	-2,040 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $61,278 - $78,467	615 Added 43.16%	2,040 $320,000
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $150,765 - $215,089	1,425 New	1,425 $243,000
Q4 2017 Feb 09, 2018	SELL	$81.25 - $130.7 $172,493 - $277,476	-2,123 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$57.74 - $91.42 $122,582 - $194,084	2,123	2,123 $292,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.